康耐视科技 CGNX 深 沪
等待开盘 04-01 09:30:00 美东时间
48.99
+3.050
+6.64%
华盛通- 最 高49.13
- 今 开46.715
- 成交量 188.15万股
- 最 低 46.69
- 昨 收 45.94
- 总市值 81.18亿
- 52周最高 59.795
- 市盈率 静 72.50
- 换手率 1.14%
- 52周最低 22.52
- 委 比 -53.66%
- 总股本 1.66亿
- 历史最高 100.31
- 量 比 1.17
- 振 幅 5.31%
- 历史最低 7.755
- 每 手 1
- 风险率 8.22%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cognex report finds 57% of manufacturers use AI machine vision systems
Cognex report finds 57% of manufacturers use AI machine vision systems Cognex published a report based on a survey of more than 500 manufacturers, system integrators, and OEMs on how AI is affecting machine-vision use in production operations. Survey results show 57% of respondents already use AI in
03-23 21:02
美股大行评级 | 能源股获大行青睐！美国铝业、康索尔能源、康菲石油、EOG能源等获上调目标价；多只航空股遭下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Altimmune"买入"评级，目标价从12美元升至25美元；BTIG：维持Jade Biosciences"买入"评级，目标价从28美元升至39美元
03-17 11:45
Barclays Maintains Overweight on Cognex, Raises Price Target to $64
Barclays analyst Guy Hardwick maintains Cognex (NASDAQ:CGNX) with a Overweight and raises the price target from $61 to $64.
03-16 22:50
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics March 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Alnylam Pharmaceuticals, Cogent Biosciences and Summit Therapeutics on Monday
03-16 18:00
Cognex Corporation Announces Annual Shareholders Meeting
Cognex Corporation Announces Annual Shareholders Meeting Cognex will hold its 2026 annual shareholders meeting in Natick, Massachusetts on April 29, 2026. Shareholders will vote on the election of three directors: Matthew Moschner, Angelos Papadimitriou and Christopher Donato. The meeting will also
03-13 20:04
美股大行评级 | 潜在涨幅148%！瑞银、小摩等8家大行首予SOLV Energy买入评级目标价42美元；甲骨文绩前遭德银等下调目标价；京东遭巴克莱下调目标价
今日重点评级关注：Evercore ISI集团：维持Caribou Biosciences"跑赢大市"评级，目标价从11美元升至13美元；富国银行：上调uniQure评级至"超配"，目标价从15美元升至60美元
03-10 15:05
Assessing Cognex: Insights From 10 Financial Analysts
In the latest quarter, 10 analysts provided ratings for Cognex (NASDAQ:CGNX), s...
03-10 04:01
JP Morgan Upgrades Cognex to Neutral, Announces $55 Price Target
JP Morgan analyst Tomohiko Sano upgrades Cognex (NASDAQ:CGNX) from Underweight to Neutral and announces $55 price target.
03-09 21:21
GXO Celebrates 20 Years of Growth in Poland Fueled by Innovation and Community Impact
GXO Logistics celebrated 20 years in Poland, marking its growth as a leader in logistics in Central Europe with over 450,000 sqm and 4,000 employees. The company, known for innovation and automation, recently opened its new Central Europe headquarters in Warsaw, honoring long-term employees. Poland's logistics market ranks fifth in Europe, reflecting its key role in the region. GXO uses advanced technologies like AMR robots and smart scanners to...
03-04 08:00
Cognex Director Angelos Papadimitriou Disposes of Common Shares
Cognex Director Angelos Papadimitriou Disposes of Common Shares Angelos Papadimitriou, Director, reported a disposal of common shares of Cognex Corporation. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative
02-25 05:56
